Aviremia 10 Years Postdiscontinuation of Antiretroviral Therapy Initiated During Primary Human Immunodeficiency Virus-1 Infection and Association With Gag-Specific T-Cell Responses.

Détails

Ressource 1Télécharger: BIB_B9F092E637B9.P001.pdf (266.71 [Ko])
Etat: Public
Version: Final published version
ID Serval
serval:BIB_B9F092E637B9
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Aviremia 10 Years Postdiscontinuation of Antiretroviral Therapy Initiated During Primary Human Immunodeficiency Virus-1 Infection and Association With Gag-Specific T-Cell Responses.
Périodique
Open Forum Infectious Diseases
Auteur⸱e⸱s
Kinloch-de Loes S., Dorrell L., Yang H., Hardy G.A., Yerly S., Cellerai C., Vandekerckhove L., De Spielgelaere W., Malatinkova E., Wee Lee Koh W., Johnson M.A.
ISSN
2328-8957 (Electronic)
ISSN-L
2328-8957
Statut éditorial
Publié
Date de publication
2015
Peer-reviewed
Oui
Volume
2
Numéro
4
Pages
ofv144
Langue
anglais
Résumé
Combination antiretroviral therapy during primary human immunodeficiency virus-1 infection may enable long-term drug-free virological control in rare individuals. We describe a female who maintained aviremia and a normal CD4(+)/CD8(+) T cell ratio for 10 years after stopping therapy, despite a persistent viral reservoir. Cellular immune responses may have contributed to this outcome.
Pubmed
Open Access
Oui
Création de la notice
21/06/2016 20:16
Dernière modification de la notice
20/08/2019 16:27
Données d'usage